Genome Wide Association Study for Predictors of Progression Free Survival in Patients on Capecitabine, Oxaliplatin, Bevacizumab and Cetuximab in First-Line Therapy of Metastatic Colorectal Cancer

PURPOSE: Despite expanding options for systemic treatment, survival for metastatic colorectal cancer (mCRC) remains limited and individual response is difficult to predict. In search of pre-treatment predictors, pharmacogenetic research has mainly used a candidate gene approach. Genome wide associat...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :PLoS One
Главные авторы: Pander, Jan, van Huis-Tanja, Lieke, Böhringer, Stefan, van der Straaten, Tahar, Gelderblom, Hans, Punt, Cornelis, Guchelaar, Henk-Jan
Формат: Artigo
Язык:Inglês
Опубликовано: Public Library of Science 2015
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4519298/
https://ncbi.nlm.nih.gov/pubmed/26222057
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0131091
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы